WMSA
HALO icon

Weiss Multi-Strategy Advisers’s Halozyme HALO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-30,000
Closed -$450K – 1028
2013
Q4 		$450K Buy
30,000
+10,000
+50% +$129K 0.01% 657
2013
Q3 		$221K Buy
+20,000
New +$167K ﹤0.01% 800

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HALO Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Halozyme (HALO) in Q4 2023, closing a stake of 38,259 shares — an estimated $1.46M sold.

Weiss Multi-Strategy Advisers first reported a position in HALO in Q4 2013 and held it in 6 quarters. The position peaked at $1.56M in Q1 2023. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 38,259 Halozyme shares in Q4 2023, an estimated $1.46M.
  • Weiss Multi-Strategy Advisers first reported a position in Halozyme in Q4 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's Halozyme position peaked at $1.56M in Q1 2023.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.